G. Türköz

Harnessing Knowledge on Very Important Pharmacogenes CYP2C9 and CYP2C19 Variation for Precision Medicine in Resource-Limited Global Conflict Zones.

H. Ankarali, Ş. Şardaş, C. Dandara, 2016, Omics : a journal of integrative biology.

Identification of GTF2IRD1 as a novel transcription factor essential for acute myeloid leukemia

H. Qian, M. Dimitriou, N. Kadri, 2022, bioRxiv.

Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis

M. Erdal, H. Ankarali, M. Sezgin, 2013, Rheumatology International.

Apoptosis-related Fas and FasL gene polymorphisms’ associations with knee osteoarthritis

M. Erdal, H. Ankarali, M. Sezgin, 2013, Rheumatology International.

The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation

H. Qian, R. Månsson, N. Kadri, 2018, Scientific Reports.

The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia

H. Qian, R. Månsson, A. Krstic, 2018, Haematologica.

The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35

O. Kepp, G. Kroemer, R. Valdivia, 2023, mBio.

The Tumor Necrosis Factor-A -308 G/A Polymorphism and the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Polymorphisms, in Asthmatic Patients and Healthy Subjects

D. Oral, M. Erdal, T. Yıldız, 2010 .